Maryland must brace for further assaults on women’s right to choose

Friday’s announcement by Gov. Wes Moore that Maryland is moving to stockpile mifepristone, the abortion pill that is now under review by the U.S. Supreme Court, was a welcome development given the uncertainties over access. Other states have made similar moves in recent days — including New York, California, Massachusetts and Washington — and we expect more to follow, at least in areas where women’s reproductive rights are still valued.